CD8A and colorectal carcinoma: This suggests that CAR T cell treatment enhances activated CD8+ T cell infiltration within a senescent tumour (157). Thus, CAR T cell immunotherapy against CRC showed favourable results both in vitro and in vivo, representing a potential candidate for combination therapy.